CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer Patients

Gastric carcinoma is a heterogeneous malignant disease involving genetic factors. To identify predictive markers for gastric cancer treatment in Chinese patients, we evaluated the association between polymorphisms of the gene encoding cytochrome P450 2A6 (CYP2A6) and outcomes of S-1 plus oxaliplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Zou, Shanshan, Shu, Chang, Song, Yan, Sun, Yong-Kun, Zhang, Wen, Zhou, Aiping, Yuan, Xinghua, Yang, Yi, Hu, Songnian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582793/
https://www.ncbi.nlm.nih.gov/pubmed/28811232
http://dx.doi.org/10.1016/j.gpb.2016.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582793/
https://www.ncbi.nlm.nih.gov/pubmed/28811232
http://dx.doi.org/10.1016/j.gpb.2016.11.004

Ejemplares similares